Suchergebnisse

Rapid advancement of telecommunications and information technology has created the potential for high-quality expert healthcare to be delivered when and where it is needed. This text charts the development of the telemedicine industry, defines its current scope and reveals the potential of new methodologies. * Explains the main features of telemedicine and telecare * Reviews the technology needed for telemedicine * Describes how to develop, deliver and evaluate telemedicine services * Considers the associated ethical and legal issues * Includes an in-depth survey of the literature with over 300 references to research articles and hyperlinks to associated websites This text provides a good working knowledge of the subject matter. It will be indispensable for all students on courses related to medicine and health care management. It also addresses the strategic, technical and operational issues faced by clinicians and health care managers considering the introduction of telemedicine services offering solutions for a variety of situations

Ethn Dis. 2018;28(Suppl 2):285-286; doi:10.18865/ed.28.S2.285.

Receipt to Alden Partridge for a one-year subscription to the "Mercury."

Innovation is synonymous with problem solving, and the basic elements of innovation apply to any business, says Robert M. Price in this essential guide for managers of organizations large or small. Distilling a set of practical principles from his forty years of experience as a pioneer in the computer industry, the author shows that innovation can be learned and practiced by everyone, that it can offer solutions to everyday problems as well as high-profile ones, and that it provides opportunities to solve business problems while meeting a variety of human needs.Former CEO of Control Data, Price weaves the history of this uniquely innovative company with fresh thinking about innovation itself-what it means to the people in an organization, the products, and the processes. He avoids simplistic prescriptions and clearly explains seven fundamental principles of innovation beginning with "innovators are made, not born." He illustrates these principles with fascinating real-life examples. His book offers both the practical tools and the inspiration to everyone with an interest in effective management practice and in building organizations that creatively and continuously respond to ever-changing social and market needs

<p>It is a time-honored tradition in medicine and public health to recognize and honor individuals and teams for their original discoveries in basic, clinical, and population science research or for a sustained commitment to patient care and teaching. In following that tradition, <em>Ethnicity &amp; Disease</em> pays special tribute to Elijah B. Saunders, MD, FACC, FACP, FAHA, FASH for his life-long commitment to patient care, teaching, community service, and most importantly, for his tireless efforts in taking many first steps to advance health equity for medically underserved communities in the United States and worldwide.¹^,² </p>

<em>Ethn Dis.</em> 2018;28(1):1-2; doi:10.18865/ed.28.1.1.

<p>Patients with chronic kidney disease (CKD) suffer from an increased prevalence of cardiovascular disease (CVD) risk factors, and a high rate of premature CV morbidity and mortality. The confluence of CV risk factors, in the context of cardio-metabolic perturbations that vary as renal function declines, complicates strategies for the care of patients with CKD. Understanding the ex­isting evidence for effective CVD treatment strategies can help providers better care for these patients, navigate the complex treat­ment guidelines, which often differ across major organizations, and minimize the con­flicting recommendations that new studies may pose. A pragmatic approach is to target a BP &lt;140/90 mm Hg, which frequently requires more than two or three antihyper­tensive agents. Most guidelines recommend a combination of diuretic and angiotensin converting enzyme inhibitor or angiotensin receptor blockers, along with a dihydropyri­dine calcium channel blocker, beta blocker or other agent based on co-existing medical conditions. Consideration for a lower BP goal and/or other therapeutic interventions should be based on the etiology of CKD, stage of CKD, and/or presence of protein­uria. Finally, most patients with CKD, not on dialysis, would benefit from treatment with statins and non-pharmacologic lifestyle interventions should be promoted for all pa­tients with CKD. <em>Ethn Dis. </em>2015;25(4):515- 520; doi:10.18865/ed.25.4.515</p>

Ethn Dis. 2020;30(3):433-436; doi:10.18865/ed.30.3.433

Prior to January 1, 1997, individuals with drug- or alcohol-related disabilities could qualify for federal public assistance through the Supplemental Security Income (SSI) program. During the welfare reforms of the Clinton administration, this policy was changed resulting in lost income and health care benefits for many low-income substance abusers. This paper examines the historical underpinnings to the elimination of drug addiction and alcoholism (DA&A) as qualifying impairments for SSI disability payments. Following this, empirical evidence is presented on the effect this policy change had on the subsequent economic security of former SSI DA&A beneficiaries. Findings indicate that study participants that lost SSI benefits suffered increased economic hardship following the policy change. These findings have important implications for future social welfare policymaking decisions.